IXHL
Price:
$1.63
Market Cap:
$28.76M
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital an...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-03-02
Stock Exchange
NASDAQ
Ticker
IXHL
According to Incannex Healthcare Limited’s latest financial reports and current stock price. The company's current ROE is -77.78%. This represents a change of 182.88% compared to the average of -27.50% of the last 4 quarters.
The mean historical ROE of Incannex Healthcare Limited over the last ten years is 1.25%. The current -77.78% ROE has changed -106.23% with respect to the historical average. Over the past ten years (40 quarters), IXHL's ROE was at its highest in in the June 2017 quarter at 570.11%. The ROE was at its lowest in in the December 2016 quarter at -549.91%.
Average
1.25%
Median
-87.10%
Minimum
-580.69%
Maximum
12.25%
Discovering the peaks and valleys of Incannex Healthcare Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.55%
Maximum Annual ROE = 12.25%
Minimum Annual Increase = -122.78%
Minimum Annual ROE = -580.69%
Year | ROE | Change |
---|---|---|
2024 | -164.56% | -29.79% |
2023 | -234.39% | 464.10% |
2022 | -41.55% | -68.68% |
2021 | -132.65% | -10.65% |
2020 | -148.45% | -122.78% |
2019 | 651.61% | -15.27% |
2018 | 769.07% | -93.72% |
2017 | 12.25% | 11.55% |
2016 | 105.21% | -118.12% |
2015 | -580.69% | -13.38% |
The current ROE of Incannex Healthcare Limited (IXHL) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-146.83%
5-year avg
-144.32%
10-year avg
1.25%
Incannex Healthcare Limited’s ROE is less than Delta 9 Cannabis Inc. (484.43%), greater than RAMM Pharma Corp. (-32.53%), less than City View Green Holdings Inc. (51.86%), greater than Craftport Cannabis Corp. (-194.22%), greater than Speakeasy Cannabis Club Ltd. (-16.76%), less than Eagle Pharmaceuticals, Inc. (17.39%), greater than ANI Pharmaceuticals, Inc. (-1.60%), less than Phibro Animal Health Corporation (6.59%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), less than Prestige Consumer Healthcare Inc. (12.35%), less than Collegium Pharmaceutical, Inc. (40.81%), less than Silver Spike Investment Corp. (0%), greater than Regencell Bioscience Holdings Limited (-48.12%), less than Procaps Group S.A. (97.17%), greater than Sihuan Pharmaceutical Holdings Group Ltd. (-0.85%),
Company | ROE | Market cap |
---|---|---|
484.43% | $1.41M | |
-32.53% | $15.16M | |
51.86% | $3.75M | |
-194.22% | $6.43B | |
-16.76% | $1.31K | |
17.39% | $11.01M | |
-1.60% | $1.20B | |
6.59% | $940.09M | |
-52.42% | $2.21B | |
12.35% | $4.17B | |
40.81% | $966.54M | |
0% | $66.72M | |
-48.12% | $76.65M | |
97.17% | $170.36M | |
-0.85% | $455.30M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Incannex Healthcare Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Incannex Healthcare Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Incannex Healthcare Limited's ROE?
How is the ROE calculated for Incannex Healthcare Limited (IXHL)?
What is the highest ROE for Incannex Healthcare Limited (IXHL)?
What is the 3-year average ROE for Incannex Healthcare Limited (IXHL)?
What is the 5-year average ROE for Incannex Healthcare Limited (IXHL)?
How does the current ROE for Incannex Healthcare Limited (IXHL) compare to its historical average?